JENNIFER WHITAKER to Influenza, Human
This is a "connection" page, showing publications JENNIFER WHITAKER has written about Influenza, Human.
Connection Strength
1.506
-
The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL). Vaccine. 2021 02 12; 39(7):1122-1130.
Score: 0.436
-
Strategies to maximize influenza vaccine impact in older adults. Vaccine. 2018 09 25; 36(40):5940-5948.
Score: 0.369
-
INSIGHT FLU005: An Anti-Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study. J Infect Dis. 2016 Feb 15; 213(4):574-8.
Score: 0.301
-
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone? or Flublok?) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45?years of age. Vaccine. 2025 04 30; 54:126991.
Score: 0.146
-
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial. J Infect Dis. 2024 02 14; 229(2):327-340.
Score: 0.135
-
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial. Lancet Respir Med. 2019 11; 7(11):951-963.
Score: 0.100
-
Vaccinology in the third millennium: scientific and social challenges. Curr Opin Virol. 2016 04; 17:116-125.
Score: 0.020